Active-ingredient Dossier
Safinamide Mesilate
Active-ingredient Dossier for Safinamide Mesilate (monoamine oxidase inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: ARX-SAFINAMIDE
- Brand: XADAGO
- Brand: XAFIMED
- Therapeutic area: Neurology
What is
Safinamide Mesilate Safinamide Mesilate is a monoamine oxidase inhibitor.
Australian brands containing
Safinamide Mesilate — XADAGO — ARX-SAFINAMIDE — XAFIMED — APO-SAFINAMIDE — MSN-SAFINAMIDE — SAFINAMIDE — XAFIN
Therapeutic areas
Safinamide Mesilate is registered in neurology, with 7 brands containing the ingredient on the ARTG.
Sponsor landscape
Safinamide Mesilate is marketed by four sponsors: Medsurge Pharma, Arrotex Pharmaceuticals, Accelagen, and Atnahs Pharma.
PBS and regulatory activity
The latest PBAC outcome for a safinamide mesilate brand was recorded on 1 November 2018, with 1 brand having a PBAC outcome on record. The latest AusPAR was issued on 30 October 2018, with 1 brand having an AusPAR on record.